How much funding has PTC Therapeutics raised?

PTC Therapeutics has raised $166.6M in total funding, most recently a Series F round.

Who are PTC Therapeutics's investors?

PTC Therapeutics's investors include Credit Suisse, J.P. Morgan, Brookside Capital Partners Fund, L.P., The Column Group, Credit Suisse First Boston Private Equity, HBM BioVentures.

When was PTC Therapeutics founded?

PTC Therapeutics was founded in 1998.

Where is PTC Therapeutics headquartered?

PTC Therapeutics is headquartered in South Plainfield, New Jersey, United States.

What industry is PTC Therapeutics in?

PTC Therapeutics operates in Biotech, Healthcare.

How many employees does PTC Therapeutics have?

PTC Therapeutics has 501-1000 employees.

PTC Therapeutics

IPO

Pioneering Rare Disease Treatments

Public · South Plainfield, United States · Founded 1998 · $166.6M raised

Biotech

Healthcare

Headquarters: South Plainfield, New Jersey
Employees: 501–1000
Founded: 1998
Business Model: B2B
Website: ptcbio.com

Total Funding: $166.6M
Last Round: $60.0M Series FMar 2013
Rounds: 5
Type: Public

About

PTC Therapeutics is a global biopharmaceutical company that discovers, develops, and commercializes clinically differentiated medicines for patients living with rare diseases of high unmet need. The company's portfolio spans metabolic conditions such as PKU and familial chylomicronemia syndrome, and neurological disorders including Duchenne muscular dystrophy, Friedreich's ataxia, and Huntington's disease. PTC applies two core scientific platforms — splicing modulation and inflammation/ferroptosis targeting — to deliver transformative therapies where few or no options exist.

Summary

PTC Therapeutics is a Biotech company based in South Plainfield, United States, founded in 1998. It has raised $166.6M in total across 5 rounds, most recently a $60.0M Series F round in Mar 2013. Investors include Credit Suisse, J.P. Morgan and Brookside Capital Partners Fund, L.P..

LinkedIn X (Twitter)